David Schorling

1.1k total citations
18 papers, 526 citations indexed

About

David Schorling is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, David Schorling has authored 18 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Surgery. Recurrent topics in David Schorling's work include Neurogenetic and Muscular Disorders Research (9 papers), RNA modifications and cancer (5 papers) and Muscle Physiology and Disorders (4 papers). David Schorling is often cited by papers focused on Neurogenetic and Muscular Disorders Research (9 papers), RNA modifications and cancer (5 papers) and Muscle Physiology and Disorders (4 papers). David Schorling collaborates with scholars based in Germany, Canada and United States. David Schorling's co-authors include Janbernd Kirschner, Astrid Pechmann, Ulrike Schara, Thorsten Langer, Sabine Stein, Sibylle Emilie Vogt, Carsten G. Bönnemann, Hanns Lochmüller, Heike Kölbel and Maggie C. Walter and has published in prestigious journals such as Neurology, Acta Paediatrica and European Journal of Neurology.

In The Last Decade

David Schorling

18 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Schorling Germany 10 408 325 241 76 39 18 526
Tamara Dangouloff Belgium 9 399 1.0× 276 0.8× 257 1.1× 50 0.7× 35 0.9× 21 468
Muna El-Khairi Switzerland 8 469 1.1× 334 1.0× 251 1.0× 36 0.5× 48 1.2× 20 526
Arlene D’Silva Australia 14 323 0.8× 239 0.7× 208 0.9× 55 0.7× 40 1.0× 23 487
Heidemarie Kletzl Switzerland 5 397 1.0× 273 0.8× 216 0.9× 27 0.4× 43 1.1× 12 442
Agata Robertson United Kingdom 5 521 1.3× 355 1.1× 311 1.3× 36 0.5× 65 1.7× 6 596
Maria Sframeli Italy 11 282 0.7× 269 0.8× 171 0.7× 26 0.3× 38 1.0× 27 441
Ksenija Gorni Switzerland 13 761 1.9× 500 1.5× 443 1.8× 51 0.7× 86 2.2× 63 833
Markus McColly United States 5 250 0.6× 269 0.8× 165 0.7× 87 1.1× 27 0.7× 12 408
B. Maru United States 6 243 0.6× 204 0.6× 145 0.6× 79 1.0× 25 0.6× 16 393
Kapil Arya United States 9 170 0.4× 188 0.6× 102 0.4× 96 1.3× 21 0.5× 23 372

Countries citing papers authored by David Schorling

Since Specialization
Citations

This map shows the geographic impact of David Schorling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Schorling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Schorling more than expected).

Fields of papers citing papers by David Schorling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Schorling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Schorling. The network helps show where David Schorling may publish in the future.

Co-authorship network of co-authors of David Schorling

This figure shows the co-authorship network connecting the top 25 collaborators of David Schorling. A scholar is included among the top collaborators of David Schorling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Schorling. David Schorling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schorling, David, et al.. (2023). Mechanographic analysis of the timed 4 stair climb test - methodology and reference data of healthy children and adolescents.. PubMed. 23(1). 4–25. 2 indexed citations
2.
Schorling, David, Heike Kölbel, Andreas Hentschel, et al.. (2022). Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy. European Journal of Neurology. 29(7). 2084–2096. 20 indexed citations
3.
Schorling, David, et al.. (2021). Post‐dural puncture headache—a single‐centre analysis in paediatric patients with and without SMA. Acta Paediatrica. 110(6). 1895–1901. 1 indexed citations
4.
Schorling, David, Astrid Pechmann, Heike Kölbel, et al.. (2020). Impaired secretion of platelet granules in patients with Duchenne muscular dystrophy – results of a prospective diagnostic study. Neuromuscular Disorders. 31(1). 35–43. 5 indexed citations
5.
Schorling, David, Astrid Pechmann, Thorsten Langer, et al.. (2020). Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey.. PubMed. 39(1). 2–12. 6 indexed citations
6.
Schorling, David, Astrid Pechmann, & Janbernd Kirschner. (2019). Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for Care. Journal of Neuromuscular Diseases. 7(1). 1–13. 164 indexed citations
7.
Pechmann, Astrid, Simone Thiele, Maggie C. Walter, et al.. (2019). De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany. Orphanet Journal of Rare Diseases. 14(1). 152–152. 17 indexed citations
8.
Pechmann, Astrid, Günther Bernert, Ulrike Schara, et al.. (2019). SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy. Orphanet Journal of Rare Diseases. 14(1). 18–18. 65 indexed citations
9.
Pechmann, Astrid, et al.. (2019). De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure. Neuromuscular Disorders. 29(11). 907–909. 7 indexed citations
10.
Schorling, David, Jutta Becker, Astrid Pechmann, et al.. (2019). Discrepancy in redetermination of SMN2 copy numbers in children with SMA. Neurology. 93(6). 267–269. 34 indexed citations
11.
Pechmann, Astrid, Simone Thiele, Maggie C. Walter, et al.. (2019). De-duplicating Patient Records from Three Independent Data Sources Reveals the Incidence of Rare Neuromuscular Disorders in Germany. Neuropediatrics. 1 indexed citations
12.
Pechmann, Astrid, Thorsten Langer, David Schorling, et al.. (2018). Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany. Journal of Neuromuscular Diseases. 5(2). 135–143. 104 indexed citations
13.
Cseh, Annamária, et al.. (2018). Successful Surgical Removal of A Massive Iliopsoas Pseudotumor in a Boy With Mild Hemophilia A. Klinische Pädiatrie. 230(6). 333–335. 2 indexed citations
14.
Evers, Christina, Katrin Hinderhofer, Rudolf Korinthenberg, et al.. (2017). Expanding Phenotype of De Novo Mutations in GNAO1: Four New Cases and Review of Literature. Neuropediatrics. 48(5). 371–377. 27 indexed citations
15.
Schorling, David, Simone Rost, Dirk J. Lefeber, et al.. (2017). Early and lethal neurodegeneration with myasthenic and myopathic features. Neurology. 89(7). 657–664. 19 indexed citations
16.
Kirschner, Janbernd, Carsten G. Bönnemann, & David Schorling. (2017). Congenital Muscular Dystrophies and Myopathies: An Overview and Update. Neuropediatrics. 48(4). 247–261. 27 indexed citations
17.
Pechmann, Astrid, et al.. (2017). Single-Center Experience with Intrathecal Administration of Nusinersen in Children with Spinal Muscular Atrophy Type I. Neuropediatrics. 48(S 01). S1–S45. 1 indexed citations
18.
Kirschner, Janbernd, David Schorling, Dieter Hauschke, et al.. (2013). Somatropin treatment of spinal muscular atrophy: A placebo-controlled, double-blind crossover pilot study. Neuromuscular Disorders. 24(2). 134–142. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamara Dangouloff Breakdown of academic impact, for papers by Muna El-Khairi Breakdown of academic impact, for papers by Arlene D’Silva Breakdown of academic impact, for papers by Heidemarie Kletzl Breakdown of academic impact, for papers by Agata Robertson Breakdown of academic impact, for papers by Maria Sframeli Breakdown of academic impact, for papers by Ksenija Gorni Breakdown of academic impact, for papers by Markus McColly Breakdown of academic impact, for papers by B. Maru Breakdown of academic impact, for papers by Kapil Arya
Rankless by CCL
2026